Abstract
Ulcerative proctitis may often be managed with topical salicylates or steroids alone, but in some patients, symptoms are persistent and severe. We analyzed the efficacy of tacrolimus suppositories in patients who had proven refractory to combined topical and systemic treatment. In this retrospective analysis, ulcerative colitis activity index (CAI), side effects, co-medication and drug levels were assessed in 43 patients with distal ulcerative colitis who received suppositories containing 2 mg of tacrolimus b.i.d. as add-on medication. A total of 23 patients with ulcerative proctitis presented to follow-up within ≤50 days (mean 27.0 days) after suppositories were started. A decrease in CAI (from 8.0 to 5.5 points) was observed and 52.3% reached clinical remission (CAI ≤4). In total, 43 patients were available for analysis, of whom 9 had inflammation of the sigmoid colon as well. For the entire cohort, the median treatment duration was 76 days; 60% were in remission on the last documented visit. Serum measurements revealed a substantial tacrolimus level with a mean of 5.5 ng/mL. We observed one case of mild reversible acute kidney injury. In ulcerative proctitis, adding tacrolimus suppositories can be an effective and safe optio...Continue Reading
References
Jan 14, 1989·BMJ : British Medical Journal·D Rachmilewitz
Dec 24, 1987·The New England Journal of Medicine·K W SchroederD M Ilstrup
Feb 18, 2006·Gut·H OgataT Hibi
Aug 21, 2007·Clinical Journal of the American Society of Nephrology : CJASN·Jeffrey SchiffMarcelo Cantarovich
Sep 3, 2008·Alimentary Pharmacology & Therapeutics·I C Lawrance, T-S Copeland
Oct 1, 2008·Inflammatory Bowel Diseases·Jolanda M van DierenC Janneke van der Woude
Dec 2, 2009·Digestive Diseases and Sciences·Jolanda M van DierenEdward E S Nieuwenhuis
Dec 3, 2010·Journal of Crohn's & Colitis·M EscherK R Herrlinger
May 18, 2011·World Journal of Gastrointestinal Pharmacology and Therapeutics·Ian Craig Lawrance
Aug 26, 2011·Zeitschrift für Gastroenterologie·A DignassA Stallmach
Sep 3, 2011·Inflammatory Bowel Diseases·Haruhiko OgataToshifumi Hibi
Nov 6, 2012·Alimentary Pharmacology & Therapeutics·K J SchmidtJ Büning
Aug 8, 2013·Pharmacogenetics and Genomics·Julia M BarbarinoRuss B Altman
Sep 12, 2013·Diseases of the Colon and Rectum·Motoi UchinoNaohiro Tomita
Oct 24, 2013·Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete·U R Hengge
Sep 27, 2014·Expert Opinion on Drug Metabolism & Toxicology·Erika B Rangel
May 20, 2015·Dermatitis : Contact, Atopic, Occupational, Drug·Brian Keng Yong Chia, Hong Liang Tey
Jul 18, 2015·Clinical Journal of Gastroenterology·Cheng Hiang LeeShoma Dutt
Mar 14, 2017·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Ian C LawranceSusan Connor
Aug 18, 2017·Inflammatory Bowel Diseases·Thomas KlagJan Wehkamp
Citations
Aug 13, 2020·JGH Open : an Open Access Journal of Gastroenterology and Hepatology·Sasha R FehilyMichael A Kamm
Jul 8, 2020·United European Gastroenterology Journal·Evelyne DuboisSéverine Vermeire
Nov 6, 2020·Diseases of the Colon and Rectum·Amy L LightnerPaulo Kotze
Dec 6, 2020·Biomedicines·Iria Seoane-ViañoAnxo Fernández-Ferreiro
Feb 25, 2021·Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research·George SalemRussell Cohen
Feb 23, 2021·Asian Journal of Pharmaceutical Sciences·Iria Seoane-ViañoAlvaro Goyanes